✦ LIBER ✦

Treatment of anaemia in dialysis patients with unit dosing of darbepoetin alfa at a reduced dose frequency relative to recombinant human erythropoietin (rHuEpo)

✍ Scribed by Locatelli, F.

Book ID: 125469953
Publisher: Oxford University Press
Year: 2003
Tongue: English
Weight: 116 KB
Volume: 18
Category: Article
ISSN: 0931-0509
DOI: 10.1093/ndt/18.2.362

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized trial of darbepoetin alfa for

Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients

✍ Vanrenterghem, Yves; BÃ¡rÃ¡ny, Peter; Mann, Johannes F.E.; Kerr, Peter G.; Wilso 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 601 KB

## Background: Darbepoetin alfa is a glycoprotein with a three-fold longer terminal half-life than recombinant human erythropoietin (rhuepo). we aimed to determine whether darbepoetin alfa is as effective and well tolerated as rhuepo for treating renal anemia in dialysis patients when administered

Darbepoetin alfa effectively maintains h

Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients

✍ Brunkhorst, R.; Bommer, J.; Braun, J.; Haag-Weber, M.; Gill, C.; Wagner, J.; Wag 📂 Article 📅 2004 🏛 Oxford University Press 🌐 English ⚖ 136 KB

Unit dosing of darbepoetin alfa for thet

Unit dosing of darbepoetin alfa for thetreatment of anemia in patients with end-stage renal disease being switched from recombinant human erythropoietin: Results of a phase IIIb, 27-week, multicenter, open-label study in Greek patients

✍ Georgios Bristoyiannis; Nikolaos Germanos; Dimitrios Grekas; Christos Hatzidimit 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 930 KB

Novel erythropoiesis stimulating protein

Novel erythropoiesis stimulating protein (NESP) corrects anemia in patients with chronic renal insufficiency (CRI) when administered at a reduced dose frequency relative to recombinant-human erythropoietin (rHuEPO): R Walker, F Locatelli, J Olivares, M Wilkie and the European/Australian NESP 980202 Study Group., Melbourne, Australia; Lecco, Italy; Alicante, Spain; and Sheffield, United Kingdom

📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 146 KB